Capital Fund Management S.A. Eli Lilly & CO Put Options Transaction History

Capital Fund Management S.A.

$33.7 Billion
Q2 2024

Put Options

28 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $26.2 Million - $32.8 Million	-36,100 Reduced 18.56%	158,400 $143 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $13 Million - $17.4 Million	22,000 Added 12.75%	194,500 $151 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $38.8 Million - $45.8 Million	73,900 Added 74.95%	172,500 $101 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $7.13 Million - $9.83 Million	16,400 Added 19.95%	98,600 $53 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $4.45 Million - $5.96 Million	-12,700 Reduced 13.38%	82,200 $38.6 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $19.5 Million - $22.9 Million	62,700 Added 194.72%	94,900 $32.6 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $20 Million - $23.3 Million	-62,100 Reduced 65.85%	32,200 $11.8 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $20.5 Million - $23.4 Million	69,300 Added 277.2%	94,300 $30.5 Billion
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $16.9 Million - $19.9 Million	-60,800 Reduced 70.86%	25,000 $8.11 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $17.6 Million - $21.8 Million	-74,800 Reduced 46.58%	85,800 $24.6 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $6.27 Million - $7.79 Million	27,900 Added 21.02%	160,600 $44.4 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $9.31 Million - $11.5 Million	42,000 Added 46.31%	132,700 $30.7 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $8.61 Million - $11.1 Million	47,700 Added 110.93%	90,700 $20.8 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $3.65 Million - $4.72 Million	22,200 Added 106.73%	43,000 $8.03 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $1.54 Million - $2.04 Million	-11,800 Reduced 36.2%	20,800 $3.51 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $4.64 Million - $5.36 Million	-31,700 Reduced 49.3%	32,600 $4.83 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $17.6 Million - $21.2 Million	-129,100 Reduced 66.75%	64,300 $10.6 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $9.94 Million - $12.3 Million	-83,500 Reduced 30.16%	193,400 $26.8 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $662,904 - $821,066	6,200 Added 2.29%	276,900 $36.4 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $1.36 Million - $1.48 Million	-12,700 Reduced 4.48%	270,700 $30.3 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $7.19 Million - $8.39 Million	-64,900 Reduced 18.63%	283,400 $31.4 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $4.71 Million - $5.54 Million	42,300 Added 13.82%	348,300 $45.2 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $11.9 Million - $13.3 Million	112,500 Added 58.14%	306,000 $35.4 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $16.3 Million - $20.3 Million	189,400 Added 4619.51%	193,500 $20.8 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $310,370 - $356,208	-4,100 Reduced 50.0%	4,100 $350,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $1.92 Million - $2.27 Million	-25,900 Reduced 75.95%	8,200 $634,000
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $671,908 - $720,698	8,200 Added 31.66%	34,100 $2.88 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $2 Million - $2.22 Million	25,900	25,900 $2.22 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

Lilly Endowment Inc Indianapolis, IN

97.4M
Shares

$85.4 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.9M
Shares

$64.8 Billion
1.31% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$57.8 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$45.1 Billion
31.1% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$29.7 Billion
1.36% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account